Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Energy Recovery Q3 2025 Earnings Call - Strong Sales Execution and Clear CO2 Commercialization Timeline
Energy Recovery reported a robust third quarter with improved mega project shipments and a rebound in wastewater revenues, allowing the company to reiterate its four-year revenue guidance while reduci...
- Energy Recovery had a strong Q3 with improved mega project shipments and wastewater revenue rebound.
- The company reiterated its four-year revenue guidance and further reduced its operating expenses guidance.
- Effective cost control measures were implemented without sacrificing investments in wastewater business growth.
- +7 more takeaways
Adaptive Biotechnologies Q3 2025 Earnings Call - MRD Business Achieves Cash Flow Positivity Amid Robust Growth
Adaptive Biotechnologies reported a strong third quarter with its minimal residual disease (MRD) business hitting key profitability milestones, including adjusted EBITDA of $7 million and becoming cas...
- MRD business achieved adjusted EBITDA of $7 million in Q3, a major profitability milestone.
- MRD segment became cash flow positive ahead of plan, underscoring scalable business model strength.
- MRD revenue grew 52% year-over-year to $56.8 million, driven by clinical volume and ASP increases.
- +17 more takeaways
e.l.f. Beauty Q2 2026 Earnings Call - Rhode Acquisition Boosts Growth Amid Core Organic Challenges
e.l.f. Beauty reported a strong Q2 fiscal 2026 with net sales up 14%, driven primarily by the acquisition of Rhode, which contributed $52 million in sales and marked a record-breaking Sephora North Am...
- e.l.f. Beauty grew Q2 net sales 14% year-over-year to $344 million, including $52 million contributed by Rhode acquisition.
- Core e.l.f. brand organic net sales declined ~3% due to shipment delays linked to retailer pricing adjustments.
- Rhode’s Sephora North America launch was record-breaking, 2.5x bigger than previous Sephora launches; expected to contribute $200 million to 2026 net sales.
- +12 more takeaways
Marqeta Q3 2025 Earnings Call - Accelerating Total Processing Volume and Strategic European Expansion Drive Profitability
Marqeta's Q3 2025 results underscore a robust acceleration in Total Processing Volume (TPV), reaching $98 billion with a 33% year-over-year increase—the highest growth rate in six quarters. This growt...
- Total Processing Volume (TPV) grew 33% year-over-year to $98 billion, marking the highest growth rate since Q1 2024 with acceleration over the prior two quarters.
- Q3 net revenue was $163 million, up 28% year-over-year, supported by broad growth across use cases and inclusion of TransactPay acquisition.
- Gross profit increased 27% to $115 million, roughly in line with revenue growth, with a gross profit take rate near 12 basis points.
- +14 more takeaways
Everspin Technologies Q3 2025 Earnings Call - MRAM Revenue Gains on LEO Satellite and Emerging Market Traction
Everspin Technologies reported Q3 2025 revenue of $14.1 million, aligning with guidance and sustaining momentum with a 22% increase in MRAM product sales year-over-year. Growth drivers include robust ...
- Q3 2025 revenue reached $14.1 million, up 16% year-over-year, matching company guidance.
- MRAM product sales totaled $12.7 million, up 22% year-over-year, driven by toggle and STT MRAM demand.
- Strong growth noted in LEO satellite market with design wins from Astro Digital and Blue Origin, multiple MRAM parts per satellite.
- +9 more takeaways
American Coastal Insurance Corporation Q3 2025 Earnings Call - Disciplined Risk Management Delivers Record Quarterly Earnings Amid Softening Market
American Coastal Insurance Corporation reported its strongest quarter to date in Q3 2025, with earnings before income taxes surpassing $42 million and net income growing 16% year over year. The compan...
- American Coastal delivered its best quarterly earnings to date with over $42 million earnings before income taxes and 16% net income growth YoY in Q3 2025.
- Total revenues grew over 10% despite normalization of G&A expenses previously offset by payroll tax credits in H1 2025.
- The company intentionally slowed premium growth in Q3 to contain exposure through peak hurricane season and meet modeled average annual loss targets tied to reinsurance agreements.
- +8 more takeaways
Hudson Technologies 3Q 2025 Earnings Call - Strong Revenue Growth Offsets Late Season Start Amid Leadership Transition
Hudson Technologies closed its third quarter of 2025 with a robust 20% revenue increase and a 32% gross margin, driven by higher sales volumes and elevated refrigerant prices. The company also secured...
- Hudson Technologies reported 20% revenue growth in Q3 2025, driven by increased sales volume and higher average refrigerant prices, especially HFCs like R-410A.
- Gross margin expanded to 32%, up 630 basis points from 2024, boosting operating income to $14 million, nearly double last year.
- Net income rose 59% to $12.4 million, or $0.27 per share, reflecting improved pricing and volume dynamics despite a late seasonal start.
- +10 more takeaways
Lyft Q3 2025 Earnings Call - Record Growth with Multiple Catalysts Positioned for 2026
Lyft reported a historic Q3 2025 marked by record active riders, driver hours, gross bookings, and a 29% year-over-year adjusted EBITDA increase. Free cash flow topped $1 billion for the trailing 12 m...
- Lyft achieved record Q3 performance: active riders grew 18% YoY, gross bookings up 16%, and adjusted EBITDA up 29%.
- Free cash flow generation surpassed $1 billion for the first time in Lyft’s history for the trailing 12 months.
- United Airlines partnership launched allowing riders to earn miles on all eligible Lyft rides, broadening customer incentives.
- +13 more takeaways
Zevra Q3 2025 Earnings Call - Miplyf Drives Growth and Prepares for European Expansion
Zevra reported strong third quarter 2025 results, highlighting the continued momentum of Miplyf, their foundational therapy for Niemann-Pick Disease Type C (NPC). With $22.4 million in net revenue fro...
- Miplyf, Zevra’s treatment for NPC, generated $22.4 million in net revenue in Q3 2025, contributing to total net revenues of $26.1 million.
- Since launch, 137 prescription enrollment forms for Miplyf have been received, representing about 40% of the diagnosed U.S. NPC patient population.
- Miplyf is recognized as the only disease-modifying therapy for NPC that halts disease progression at 12 months with a rapid onset of effect within 12 weeks.
- +7 more takeaways
System1 Q3 2025 Earnings Call - Navigating Marketing Disruption While Accelerating Product Growth
System1’s Q3 2025 earnings reflect a challenging quarter marked primarily by the abrupt wind-down of Google’s AdSense for Domains (AFD) product, a major monetization source that led to a sharp 43% dec...
- System1’s Q3 2025 total revenue was approximately $62 million, down 31% year-over-year, mainly driven by a 43% decline in marketing revenue due to Google’s AFD product shutdown.
- Adjusted gross profit for the quarter was $36 million, down 4% year-over-year, with adjusted EBITDA at $9.9 million, also down 4%.
- Google’s AdSense for Domains (AFD), which historically contributed around 27% of the company’s marketing revenue, was effectively discontinued by the end of Q3, impacting marketing segment results severely.
- +9 more takeaways